Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KNOBL P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 61 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laczika, K; Mitterbauer, G; Mitterbauer, M; Knobl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
      Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions

      LEUKEMIA & LYMPHOMA
    2. Rintelen, C; Pabinger, I; Bettelheim, P; Lechner, K; Kyrle, PA; Knobl, P; Schneider, B; Mannhalter, C
      Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    3. Kurz, M; Knobl, P; Kalhs, P; Greinix, HT; Hocker, P; Panzer, S
      Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test

      TRANSFUSION
    4. Jansen, M; Derfler, K; Horl, WH; Knobl, P
      Treatment of acquired Factor VIII autoantibodies by immunoadsorption

      BRITISH JOURNAL OF HAEMATOLOGY
    5. Jansen, M; Schmaldienst, S; Banyai, S; Quehenberger, P; Pabinger, I; Derfler, K; Horl, WH; Knobl, P
      Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
      Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)

      LEUKEMIA & LYMPHOMA
    7. Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jager, U; Rosenmayr, A; Knobl, P; Schwarzinger, I; Hocker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P
      Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia

      ANNALS OF HEMATOLOGY
    8. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
      Fludarabine therapy in Waldenstrom's macroglobulinemia

      ANNALS OF HEMATOLOGY
    9. Stoiser, B; Knobl, P; Fonatsch, C; Haas, OA; Mitterbauer, G; Weltermann, A; Geissler, K; Valent, P; Sperr, W; Pabinger, I; Lechner, K; Jaeger, U
      Prognosis of patients with a second relapse of acute myeloid leukemia

      LEUKEMIA
    10. Schmaldienst, S; Goldammer, A; Spitzauer, S; Derfler, K; Horl, WH; Knobl, P
      Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption

      AMERICAN JOURNAL OF KIDNEY DISEASES
    11. Schulenburg, A; Kalhs, P; Worel, N; Hocker, P; Knobl, P; Greinix, HT
      Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases

      BONE MARROW TRANSPLANTATION
    12. Exner, M; Thalhammer, R; Kapiotis, S; Mitterbauer, G; Knobl, P; Haas, OA; Jager, U; Schwarzinger, I
      The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?

      CYTOMETRY
    13. Geissler, K; Gisslinger, H; Knobl, P; Sperr, W; Valent, P; Dieckmann, K; Chott, A; Potter, R; Lechner, K; Jager, U
      Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience

      WIENER KLINISCHE WOCHENSCHRIFT
    14. Worel, N; Greinix, HT; Schneider, B; Kurz, M; Rabitsch, W; Knobl, P; Reiter, E; Derfler, K; Fischer, G; Hinterberger, W; Hocker, P; Kalhs, P
      Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems

      TRANSFUSION
    15. Kurz, M; Eichelberger, B; Greinix, H; Hocker, P; Kahls, P; Knobl, P; Mayr, WR; Panzer, S
      Platelet antibodies and fever: Their association in multitransfused patients with hemato-oncological diseases

      INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    16. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
      Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment

      ANNALS OF HEMATOLOGY
    17. Stohlawetz, P; Stiegler, G; Knobl, P; Hocker, P; Panzer, S
      The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions

      ANNALS OF HEMATOLOGY
    18. Heis, N; Rintelen, C; Gisslinger, B; Knobl, P; Lechner, K; Gisslinger, H
      The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera

      EUROPEAN JOURNAL OF HAEMATOLOGY
    19. Gisslinger, H; Rodeghiero, F; Ruggeri, M; Fard, NHV; Mannhalter, C; Papagiannopoulos, M; Rintelen, C; Lalouschek, W; Knobl, P; Lechner, K; Pabinger, I
      Homocysteine levels in polycythaemia vera and essential thrombocythaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    20. MUSTAFA S; MANNHALTER C; RINTELEN C; KYRLE PA; KNOBL P; LECHNER K; PABINGER I
      CLINICAL-FEATURES OF THROMBOPHILIA IN FAMILIES WITH GENE DEFECTS IN PROTEIN-C OR PROTEIN-S COMBINED WITH FACTOR-V-LEIDEN

      Blood coagulation & fibrinolysis
    21. Knobl, P; Lechner, K
      Acquired factor V inhibitors

      BAILLIERES CLINICAL HAEMATOLOGY
    22. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    23. WELTERMANN A; MITTERBAUER GJ; MITTERBAUER M; HATTEY E; SPEISER W; GISSLINGER H; KNOBL P; EICHINGER S
      DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)

      Wiener Klinische Wochenschrift
    24. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    25. KNOBL P; RINTELEN C; KORNEK G; WILTSCHKE C; KALHS P; SCHWARZINGER I; GLOBITS S; STAUDINGER T; LACZIKA K; KYRLE P; FRASS M
      PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS

      Intensive care medicine
    26. GISSLINGER H; RINTELEN C; MUSIL N; KNOBL P; LECHNER K; PABINGER I
      ELEVATED LEVELS OF HOMOCYSTEINE IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA

      Thrombosis and haemostasis
    27. KNOBL P; RINTELEN C; KORNEK G; WILTSCHKE C; KYRLE P; FRASS M
      THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN CRITICALLY ILL PATIENTS

      Thrombosis and haemostasis
    28. SCHUH J; NIESSNER H; PAPAGIANNOPOULOS M; SCHNEIDER B; KNOBL P; PABINGER I
      HYPERHOMOCYSTEINEMIA IS NOT ASSOCIATED WITH POSTOPERATIVE VENOUS THROMBOEMBOLISM IN ORTHOPEDIC-SURGERY

      Thrombosis and haemostasis
    29. KNOBL P; TRIBL B; LECHNER K
      ACQUIRED FACTOR-V INHIBITORS - A REVIEW OF THE LITERATURE

      Thrombosis and haemostasis
    30. GEISSLER K; KOLLER E; HUBMANN E; NIEDERWIESER D; HINTERBERGER W; GEISSLER D; KYRLE P; KNOBL P; PABINGER I; THALHAMMER R; SCHWARZINGER I; MANNHALTER C; JAEGER U; HEINZ R; LINKESCH W; LECHNER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY

      Blood
    31. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Blood
    32. THALHAMMERSCHERRER R; KNOBL P; KORNINGER L; SCHWARZINGER I
      AUTOMATED 5-PART WHITE-BLOOD-CELL DIFFERENTIAL COUNTS - EFFICIENCY OFSOFTWARE-GENERATED WHITE-BLOOD-CELL SUSPECT FLAGS OF THE HEMATOLOGY-ANALYZERS SYSMEX-SE-9000, SYSMEX-NE-8000, AND COULTER-STKS

      Archives of pathology and laboratory medicine
    33. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
      FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA

      Annals of hematology
    34. MITTERBAUER M; FRITZERSZEKERES M; MITTERBAUER G; SIMONITSCH I; KNOBL P; RINTELEN C; SCHWARZINGER I; HAAS OA; SILBERBAUER K; FREY K; BIBUS B; PABINGER I; RADASZKIEWICZ T; LECHNER K; JAEGER U
      SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA

      Annals of hematology
    35. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
      DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY

      Annals of hematology
    36. RINTELEN C; PABINGER I; KNOBL P; LECHNER K; MANNHALTER C
      PROBABILITY OF RECURRENCE OF THROMBOSIS IN PATIENTS WITH AND WITHOUT FACTOR-V LEIDEN

      Thrombosis and haemostasis
    37. KURZ M; GREINIX H; HOCKER P; KALHS P; KNOBL P; MAYR WR; POBER M; PANZER S
      SPECIFICITIES OF ANTIPLATETLET ANTIBODIES IN MULTITRANSFUSED PATIENTSWITH HAEMATO-ONCOLOGICAL DISORDERS

      British Journal of Haematology
    38. RINTELEN C; MANNHALTER C; IRELAND H; LANE DA; KNOBL P; LECHNER K; PABINGER I
      ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN

      British Journal of Haematology
    39. WALCHSHOFER S; BAGHESTANIAN M; GAIGER A; KNOBL P; MOSBERGER I; SIMONITSCH I; CHOTT A; LECHNER K; VALENT P; SILLABER C
      ANTIGENIC CHARACTERIZATION OF HUMAN BONE-MARROW ENDOSTEAL CELLS - A STEM-CELL HYPOTHESIS REANALYZED

      Blood
    40. SCHOLTEN C; FODINGER M; MITTERBAUER M; LACZIKA K; MITTERBAUER G; HAAS OA; KNOBL P; SCHWARZINGER I; THALHAMMER R; PURTSCHER B; GEISSLER K; MANNHALTER C; LECHNER K; JAEGER U
      KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Annals of hematology
    41. TRIBL B; KNOBL P; DERFLER K; KAPIOTIS S; ASPOCK G; JAGER U; HORL W; LECHNER K
      RAPID ELIMINATION OF A HIGH-TITER SPONTANEOUS FACTOR-V ANTIBODY BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION AND IMMUNOSUPPRESSION

      Annals of hematology
    42. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIERDOBERSBERGER T; HORL W; LECHNER K; PABINGER I
      ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))

      Thrombosis and haemostasis
    43. RINTELEN C; KNOBL P; OVISSI L; PABINGER I; MANNHALTER C
      FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT)

      Thrombosis and haemostasis
    44. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIENDOBERSBERGER T; TRIBL B; SPEISER W; DRUML W; PABINGER I; LECHNER K
      ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS

      Thrombosis and haemostasis
    45. KALHS P; BRUGGER S; SCHWARZINGER I; GREINIX HT; KEIL F; KYRLE PA; KNOBL P; SCHNEIDER B; HOCKER P; LINKESCH W; LECHNER K
      MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION - ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS

      Transplantation
    46. MITTERBAUER G; FODINGER M; SCHERRER R; KNOBL P; JAGER U; LACZIKA K; SCHWARZINGER I; GAIGER A; GEISSLER K; GREINIX H; KALHS P; LINKESCH W; LECHNER K; MANNHALTER C
      PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA

      British Journal of Haematology
    47. RINTELEN C; PABINGER I; KNOBL P; LECHNER K; MANNHALTER C
      ORAL-CONTRACEPTIVES ARE THE MOST IMPORTANT PRECIPITATING FACTOR FOR VENOUS THROMBOSIS IN YOUNG FEMALES HOMOZYGOUS FOR ARG-506 GLN MUTATION IN THE FACTOR-V GENE

      Blood
    48. GISSLINGER H; RINTELEN C; MANNHALTER C; PABINGER I; GEISSLER K; KNOBL P; EICHINGER S; LECHNER K
      FACTOR-V LEIDEN MUTATION IS NOT A MAJOR CAUSE OF THROMBOTIC TENDENCY IN ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA-VERA (PV)

      Blood
    49. SCHERRER R; BETTELHEIM P; GEISSLER K; JAGER U; KNOBL P; KYRLE PA; LACZIKA K; MITTERBAUER G; NEUMANN E; SCHNEIDER B; SCHWARZINGER I; LECHNER K
      HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY

      Annals of hematology
    50. KUSEC R; LACZIKA K; KNOBL P; FRIEDL J; GREINIX H; KAHLS P; LINKESCH W; SCHWARZINGER I; MITTERBAUER G; PURTSCHER B; HAAS OA; LECHNER K; JAEGER U
      AML1 ETO FUSION MESSENGER-RNA CAN BE DETECTED IN REMISSION BLOOD-SAMPLES OF ALL PATIENTS WITH T(821) ACUTE MYELOID-LEUKEMIA AFTER CHEMOTHERAPY OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION/

      Leukemia
    51. LACZIKA K; MITTERBAUER G; KORNINGER L; KNOBL P; SCHWARZINGER I; KAPIOTIS S; HAAS OA; KYRLE PA; PONT J; OEHLER L; PURTSCHER B; THALHAMMER F; LECHNER K; JAEGER U
      RAPID ACHIEVEMENT OF PML-RAR-ALPHA POLYMERASE CHAIN-REACTION (PCR)-NEGATIVITY BY COMBINED TREATMENT WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA - A PILOT-STUDY

      Leukemia
    52. KNOBL P; SCHERNTHANER G; SCHNACK C; PIETSCHMANN P; PROIDL S; PRAGER R; VUKOVICH T
      HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN LEAN TYPE-2 DIABETIC-PATIENTS

      Thrombosis and haemostasis
    53. KNOBL P; PIETSCHMANN P; SCHNACK C; PRAGER R; SCHERNTHANER G
      APOLIPOPROTEIN(A) LEVELS IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS ARE UNRELATED TO METABOLIC CONTROL OR VASCULAR-DISEASE

      Wiener Klinische Wochenschrift
    54. SCHNACK C; PIETSCHMANN P; KNOBL P; SCHULLER E; PRAGER R; SCHERNTHANER G
      APOLIPOPROTEIN (A) LEVELS AND ATHEROGENIC LIPID FRACTIONS IN RELATIONTO THE DEGREE OF URINARY ALBUMIN EXCRETION IN TYPE-2 DIABETES-MELLITUS

      Nephron
    55. WILTSCHKE C; KMENT G; SWOBODA H; KNOBL P; KORNEK GV; GLOBITS S; STAUDINGER T; FRASS M
      VENTILATION WITH THE COMBITUBE DURING TRACHEOTOMY

      The Laryngoscope
    56. KORNINGER L; KNOBL P; LACZIKA K; MUSTAFA S; QUEHENBERGER P; SCHWARZINGER I; LECHNER K; JAEGER U; MANNHALTER C
      PML-RAR-ALPHA PCR POSITIVITY IN THE BONE-MARROW OF PATIENTS WITH APL PRECEDES HEMATOLOGICAL RELAPSE BY 2-3 MONTHS

      British Journal of Haematology
    57. GEISSLER K; KOLLER E; HINTERBERGER W; NIEDERWIESER D; KNOBL P; PABINGER I; WERNER D; SCHERRER R; SCHWARZINGER I; FRIEDL J; JAEGER U; LECHNER K
      CONCOMITANT ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - 1ST RESULTS OF A MULTICENTER, OPEN-LABEL, PHASE-III STUDY INRANDOMIZED PARALLEL GROUPS

      Blood
    58. KALHS P; BRUGGER S; SCHWARZINGER I; GREINIX HT; KEIL F; KYRLE PA; KNOBL P; LINKESCH W; LECHNER K
      SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION

      Blood
    59. KNOBL P; SCHNACK C; PROIDL S; PRAGER R; VUKOVICH T; SCHERNTHANER G
      HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN TYPE-2 DIABETES-MELLITUS

      Thrombosis and haemostasis
    60. KNOBL P; KAPIOTIS S; LACZIKA K; JAGER U; KYRLE A; SPEISER W; LECHNER K
      ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID

      Thrombosis and haemostasis
    61. KNOBL P; SCHERNTHANER G; SCHNACK C; PIETSCHMANN P; GRIESMACHER A; PRAGER R; MULLER M
      THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE INTYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS

      Diabetologia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 23:42:33